Sana Biotechnology, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sana Biotechnology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2024.
  • Sana Biotechnology, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $11.4M, a 15.6% increase year-over-year.
  • Sana Biotechnology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $37.4M, a 4.75% decline year-over-year.
  • Sana Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $35.5M, a 7.31% decline from 2022.
  • Sana Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $38.3M, a 71.4% increase from 2021.
  • Sana Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $22.4M, a 284% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $37.4M $11.4M +$1.53M +15.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $35.9M $9.09M +$341K +3.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $35.5M $7.93M -$2.66M -25.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $38.2M $9M -$1.08M -10.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $39.3M $9.85M -$63K -0.64% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $39.3M $8.75M +$996K +12.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $38.3M $10.6M +$3.28M +44.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $35.1M $10.1M +$4.13M +69.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $30.9M $9.91M +$4.97M +101% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $26M $7.76M +$3.6M +86.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $22.4M $7.31M +$4.52M +162% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $17.8M $5.95M +$4.78M +410% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $13.1M $4.94M +$3.83M +343% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $9.23M $4.16M +$3.4M +451% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $5.83M $2.79M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-16
Q3 2020 $1.17M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $1.12M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $755K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.